In October 2019, Johnson & Johnson (J&J) issued a voluntary recall of a single lot of its Baby Powder. The Food and Drug Administration (FDA), when testing one sample of that Baby Powder, had discovered sub-trace levels of asbestos, so J&J implemented the recall out…
The Food and Drug Administration (FDA) recently announced a recall of three lots of Mylan nizatidine capsules because tests indicated the presence of trace amounts of N-nitrosodimethylamine (NDMA). NDMA has been classified as a probable human carcinogen and is the same chemical that has recently…
In September 2019, the U.S. Food and Drug Administration (FDA) warned healthcare providers and patients that ranitidine drugs, including brand-name Zantac, had been found to contain N-nitrosodimethylamine (NDMA), a probable human carcinogen. The warning sent ripples through the healthcare community, with patients rushing to their…
On December 18, 2019, the Food and Drug Administration (FDA) announced yet another generic ranitidine recall, this time implemented by Glenmark Pharmaceutical Inc. The company is pulling all prescription ranitidine tablets (150 mg and 300 mg) from the U.S. market because they may contain unacceptable…
Nine plaintiffs have jointly filed a new Zantac cancer lawsuit in the U.S. District Court for the District of New Jersey. The plaintiffs have named as defendants all Zantac manufacturers, including Boehringer Ingelheim Pharmaceuticals, Chattem Inc., GlaxoSmithKline, Pfizer, and the current manufacturer, Sanofi. All plaintiffs…
Two plaintiffs—one from New York and the other from Virginia—recently filed a new generic Zantac (ranitidine) class-action lawsuit in the U.S. District Court for the Southern District of New York. The plaintiffs claim that generic ranitidine manufacturer Perrigo Company put consumers at risk when selling…
Following a wave of Zantac and generic ranitidine recalls, a Colorado man has filed a new Zantac lawsuit against the manufacturers of the heartburn medication. The plaintiff alleges that he used Zantac for about 23 years, and as a result, developed bladder cancer. He filed…
While Zantac (ranitidine) manufacturer Sanofi maintains that its product is safe, Australian drug regulators recently announced that three-quarters of the ranitidine samples they tested contained high levels of N-nitrosodimethylamine (NDMA), a probable human carcinogen. Sanofi recently recalled Zantac in both the U.S. and Canada amidst…
Amidst rising concerns that some medications may be contaminated with a potential cancer-causing agent, Zantac manufacturer Sanofi recently announced a recall of the heartburn medication in both the United States and Canada. The company stated it was initiating a voluntary recall “as a precautionary measure”…
On September 24, 2019, the Food and Drug Administration (FDA) alerted healthcare professionals and the public to a voluntary recall of 14 lots of prescription ranitidine capsules distributed by Sandoz, Inc. The medication helps decrease stomach acid, and is used to treat ulcers, reflux esophagitis,…